EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti-dengue activity of synthetic peptides increases antiviral interferon-beta genes in LLC-MK2 cells

Jundee Rabablert, Promsin Masrinoul, Sutee Yoksan, Supoth Rajakam, Supanyika Sengsai, Korakot Changirakul, Prayad Sangngam, Sunee Techaarpornkul, Sittiruk Roytrakul

Science, Engineering and Health Studies · 2021

DOI: 10.69598/sehs.15.21030006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, Engineering and Health Studies, 2021. Verfasst von Jundee Rabablert und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue virus (DV) causes dengue diseases in human via the Aedes mosquitoes. Fatal cases of dengue hemorrhagic fevers show a complication of acute kidney injury. Previous reports revealed that synthetic DV2(413-440), DV2(413-447), and DV2(419-447) peptides inhibit the dengue envelope proteins in Aedes albopictus C6/36 cells, but nothing is known about the effect of these peptides on mammalian cells in relation to adaptive and innate immunities. In this study, the anti-dengue activity of these synthetic peptides in Rhesus monkey kidney LLC-MK2 cells was investigated at the cellular and molecular levels. Moreover, the effects of these synthetic peptides on apoptotic caspase-10, pro-inflammatory interleukin-1beta, tumor necrosis factor-alpha, and antiviral interferon-beta genes in LLC-MK2 cells were also sought. The results revealed the maximum non-toxic doses of DV2 (413-440), DV2 (413-447), and DV2 (419-447) in LLC-MK2 cells, with values of 77.88± 0.52, 47.01±1.32, and 63.82±1.97 µM, respectively. At 25 µM concentration, synthetic DV2 (413-447) and DV2 (419-447) peptides showed 100% plaque inhibition in simultaneous treatment. By contrast, these peptides showed ≤58% plaque inhibition in pre- and post-treatment at 7 days post-incubation. These synthetic peptides also inhibited Dengue 2 virus, apoptotic caspase-10, pro-inflammatory tumor necrosis factor-alpha, and interleukin-1beta genes. On the other hand, these peptides upregulated the antiviral interferon-beta gene in innate immunity. This study is the first report to reveal the anti-dengue activity of synthetic DV2 (413-440), DV2 (413-447), and DV2 (419-447) peptides in adaptive and innate immunity.

Zitieren

APA

Rabablert, J., Masrinoul, P., Yoksan, S., Rajakam, S., Sengsai, S., Changirakul, K., Sangngam, P., Techaarpornkul, S., & Roytrakul, S. (2021). Anti-dengue activity of synthetic peptides increases antiviral interferon-beta genes in LLC-MK2 cells. Science, Engineering and Health Studies. https://doi.org/10.69598/sehs.15.21030006

Vancouver

Rabablert J, Masrinoul P, Yoksan S, Rajakam S, Sengsai S, Changirakul K, et al. Anti-dengue activity of synthetic peptides increases antiviral interferon-beta genes in LLC-MK2 cells. Science, Engineering and Health Studies. 2021. doi:10.69598/sehs.15.21030006

BibTeX
@article{Rabablert2021,
  author = {Rabablert, Jundee and Masrinoul, Promsin and Yoksan, Sutee and Rajakam, Supoth and Sengsai, Supanyika and Changirakul, Korakot and Sangngam, Prayad and Techaarpornkul, Sunee and Roytrakul, Sittiruk},
  title = {Anti-dengue activity of synthetic peptides increases antiviral interferon-beta genes in LLC-MK2 cells},
  journal = {Science, Engineering and Health Studies},
  year = {2021},
  doi = {10.69598/sehs.15.21030006}
}
Kostenlos starten →